z-logo
open-access-imgOpen Access
INHIBITION OF SODIUM GLUCOSE TRANSPORT PROTEIN 2: CLINICAL AND PHARMACOLOGICAL EFFECTS IN CHRONIC HEART FAILURE
Author(s) -
GENSHAT S. GALYAUTDINOV,
ALEXANDER G. ZHIDYAEVSKIJ,
Maria K. Nesterina,
KARINA R. MINNEGALIMOVA
Publication year - 2022
Publication title -
vestnik sovremennoj kliničeskoj mediciny
Language(s) - English
Resource type - Journals
eISSN - 2079-553X
pISSN - 2071-0240
DOI - 10.20969/vskm.2022.15(2).89-94
Subject(s) - medicine , heart failure , canagliflozin , diabetes mellitus , myocardial infarction , sodium , exacerbation , glucose transporter , cardiology , stroke (engine) , type 2 diabetes , blood pressure , endocrinology , pharmacology , insulin , chemistry , mechanical engineering , organic chemistry , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here